ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 109 filers reported holding ANI PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $443,753 | +62.5% | 7,643 | +50.7% | 0.00% | – |
| Q2 2023 | $273,080 | -13.1% | 5,073 | -35.9% | 0.00% | – |
| Q1 2023 | $314,186 | +38.5% | 7,910 | +40.3% | 0.00% | – |
| Q4 2022 | $226,777 | +27.4% | 5,637 | +1.5% | 0.00% | – |
| Q3 2022 | $178,000 | -95.7% | 5,553 | -96.0% | 0.00% | -100.0% |
| Q2 2022 | $4,153,000 | -16.2% | 139,984 | -20.6% | 0.00% | 0.0% |
| Q1 2022 | $4,954,000 | -52.6% | 176,242 | -22.2% | 0.00% | -60.0% |
| Q4 2021 | $10,443,000 | +65.3% | 226,640 | +17.8% | 0.01% | +66.7% |
| Q3 2021 | $6,317,000 | +35.9% | 192,474 | +45.1% | 0.00% | +50.0% |
| Q2 2021 | $4,648,000 | +9.7% | 132,612 | +13.1% | 0.00% | 0.0% |
| Q1 2021 | $4,238,000 | +14.3% | 117,280 | -8.2% | 0.00% | 0.0% |
| Q4 2020 | $3,709,000 | +4.5% | 127,714 | +1.5% | 0.00% | 0.0% |
| Q3 2020 | $3,550,000 | -12.5% | 125,826 | +0.4% | 0.00% | -33.3% |
| Q2 2020 | $4,055,000 | -19.7% | 125,378 | +1.2% | 0.00% | -40.0% |
| Q1 2020 | $5,048,000 | -28.3% | 123,924 | +8.5% | 0.01% | 0.0% |
| Q4 2019 | $7,044,000 | -76.7% | 114,231 | -72.4% | 0.01% | -76.2% |
| Q3 2019 | $30,195,000 | +15.8% | 414,360 | +30.6% | 0.02% | +40.0% |
| Q2 2019 | $26,069,000 | +67.8% | 317,163 | +44.0% | 0.02% | +66.7% |
| Q1 2019 | $15,535,000 | +203.8% | 220,271 | +93.9% | 0.01% | +125.0% |
| Q4 2018 | $5,113,000 | -72.2% | 113,591 | -65.1% | 0.00% | -20.0% |
| Q3 2018 | $18,420,000 | -24.9% | 325,813 | -11.3% | 0.01% | -28.6% |
| Q2 2018 | $24,529,000 | +131.4% | 367,220 | +101.6% | 0.01% | +40.0% |
| Q1 2018 | $10,602,000 | +2.9% | 182,121 | +13.9% | 0.01% | -28.6% |
| Q4 2017 | $10,308,000 | +31.9% | 159,957 | +7.4% | 0.01% | +40.0% |
| Q3 2017 | $7,817,000 | -1.6% | 148,975 | -12.3% | 0.01% | -16.7% |
| Q2 2017 | $7,944,000 | +7.0% | 169,780 | +13.2% | 0.01% | +20.0% |
| Q1 2017 | $7,424,000 | +8.8% | 149,980 | +33.2% | 0.01% | 0.0% |
| Q4 2016 | $6,826,000 | -16.9% | 112,634 | -9.0% | 0.01% | -16.7% |
| Q3 2016 | $8,215,000 | +32.3% | 123,834 | +11.3% | 0.01% | +50.0% |
| Q2 2016 | $6,208,000 | +74.1% | 111,258 | +5.0% | 0.00% | +33.3% |
| Q1 2016 | $3,565,000 | -63.9% | 105,943 | -51.6% | 0.00% | -57.1% |
| Q4 2015 | $9,885,000 | +44.3% | 219,082 | +26.4% | 0.01% | +40.0% |
| Q3 2015 | $6,848,000 | -10.5% | 173,363 | +40.6% | 0.01% | 0.0% |
| Q2 2015 | $7,649,000 | +8.1% | 123,289 | +9.0% | 0.01% | +25.0% |
| Q1 2015 | $7,073,000 | +238.4% | 113,094 | +204.9% | 0.00% | +300.0% |
| Q4 2014 | $2,090,000 | +208900.0% | 37,093 | +55262.7% | 0.00% | – |
| Q3 2014 | $1,000 | 0.0% | 67 | +97.1% | 0.00% | – |
| Q2 2014 | $1,000 | -99.6% | 34 | -99.6% | 0.00% | – |
| Q1 2014 | $264,000 | – | 8,445 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
| Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
| Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
| Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
| 1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
| THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
| Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
| Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |